XNCR Xencor Inc.

21.85
-0.29  -1%
Previous Close 22.14
Open 22.10
Price To book 3.40
Market Cap 1025340529
Shares 46,926,340
Volume 57,809
Short Ratio 13.20
Av. Daily Volume 171,264

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial initiated March 2016. Initial data due 2018 or early 2019.
XmAb5871
Systemic Lupus Erythematosus (SLE)
Phase 2 top-line data due in 2017.
XmAb5871
IgG4-Related Disease (IgG4-RD)